BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 9007118)

  • 21. Paclitaxel combined with carboplatin in the first-line treatment of advanced ovarian cancer.
    Meerpohl HG; du Bois A; Kühnle H; Lück HJ; Kreienberg R; Möbus V; Bauknecht T; Köchli O; Bochtler H; Diergarten K
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):7-12. PubMed ID: 8643973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I study of paclitaxel administered as a 1-hour infusion: toxicity and pharmacokinetics.
    Maier-Lenz H; Hauns B; Haering B; Koetting J; Mross K; Unger C; Bauknecht T; du Bois A; Meerpohl HG; Hollaender N; Diergarten K
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-16-S19-19. PubMed ID: 9427259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I/II study of paclitaxel and radiotherapy in non-small cell lung cancer.
    Marangolo M; Emiliani E; Rosti G; Giannini M; Vertogen B; Zumaglini F
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):124-7. PubMed ID: 9007139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paclitaxel (Taxol): phase I/II trial comparing 1-hour infusion schedules.
    Greco FA; Hainsworth JD
    Semin Oncol; 1994 Oct; 21(5 Suppl 8):3-8. PubMed ID: 7939760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis.
    Strauss GM; Lynch TJ; Elias AD; Jacobs C; Herbst R; Leong T; Lynch C; Kwiatkowski DJ; Carey RW; Grossbard ML; Skarin AT
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-73-S12-80. PubMed ID: 9331127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paclitaxel administered by a 1-hour infusion: A phase I-II trial comparing two schedules.
    Hainsworth JD; Raefsky EL; Greco FA
    Cancer J Sci Am; 1995; 1(4):281-7. PubMed ID: 9166489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-agent paclitaxel as a 3-hour infusion.
    Gatzemeier U; Neuhauss R; Schluter I; von Pawel J; Wagner H; Diergarten K
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):94-7. PubMed ID: 9007132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of patients with upper gastrointestinal carcinomas.
    Ajani JA
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-72-S19-76. PubMed ID: 9427271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paclitaxel and radiotherapy in the treatment of advanced non-small cell lung cancer.
    Marangolo M; Emiliani E; Rosti G; Giannini M; Vertogen B; Zumaglini F
    Semin Oncol; 1996 Dec; 23(6 Suppl 15):31-4. PubMed ID: 8996595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-dense therapy with paclitaxel via weekly 1-hour infusion: preliminary experience in the treatment of metastatic breast cancer.
    Seidman AD; Hudis CA; McCaffrey J; Tong W; Currie V; Moynahan ME; Theodoulou M; Tepler I; Gollub M; Norton L
    Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-72-S17-76. PubMed ID: 9374099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paclitaxel and simultaneous radiation in the treatment of stage IIIA/B non-small cell lung cancer.
    Wolf M; Faoro C; Goerg C; Pfab R; Havemann K; Kettner H
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):108-12. PubMed ID: 9007135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. One-hour paclitaxel in the treatment of non-small cell lung cancer.
    Hainsworth JD; Greco FA
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):98-101. PubMed ID: 9007133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paclitaxel and weekly 24-hour infusion of 5-fluorouracil/folinic acid in advanced gastric cancer.
    Bokemeyer C; Hartmann JT; Lampe CS; Clemens MR; Quietzsch D; Forkmann L; Kanz L
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-96-S19-100. PubMed ID: 9427277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pilot study with fixed-dose carboplatin and escalating paclitaxel in advanced ovarian cancer.
    Bolis G
    Semin Oncol; 1995 Dec; 22(6 Suppl 14):32-4. PubMed ID: 8553081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase I dose finding study of a biweekly schedule of a fixed dose of cisplatin with increasing doses of paclitaxel in patients with advanced esophageal cancer.
    van der Gaast A; Kok TC; Vos R; Kerkhofs L; Splinter TA
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-82-S19-85. PubMed ID: 9427273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preliminary results of a phase II study of paclitaxel and cisplatin in patients with non-small cell lung cancer.
    Sørensen JB; Wedervang K; Dombernowsky P
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-18-S12-20. PubMed ID: 9331114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of escalating doses of paclitaxel plus cisplatin in patients with inoperable head and neck cancer.
    Hitt R; Hornedo J; Colomer R; Hidalgo M; Brandariz A; Peña M; Vicent JA; Cortés-Funes H
    Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-58-S2-64. PubMed ID: 9045339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paclitaxel plus carboplatin and concurrent radiation therapy for patients with locally advanced non-small cell lung cancer.
    Choy H; Akerley W; Safran H; Graziano S; Chung C
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):117-9. PubMed ID: 9007137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM; Glisson BS; Khuri FR; Ginsberg L; Lawhorn K; Hong WK; Lippman SM
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-33-S19-37. PubMed ID: 9427263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paclitaxel combined with carboplatin in the first-line treatment of advanced ovarian cancer: a phase I trial.
    Meerpohl HG; du Bois A; Luck HJ; Kühnle H; Möbus V; Kreienberg R; Bauknecht T; Köchli O; Bochtler H; Diergarten K
    Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-17-S2-22. PubMed ID: 9045330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.